Skip to Content

210 (Uro-458 hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg)

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate

Pill with imprint 210 is Blue, Capsule-shape and has been identified as Uro-458 hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg. It is supplied by Method Pharmaceuticals, LLC.

Uro-458 is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uro-458 hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 210

Uro-458

Generic Name
hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Imprint
210
Strength
hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg
Color
Blue
Size
15.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Method Pharmaceuticals, LLC
National Drug Code (NDC)
58657-0458
Inactive Ingredients
polyethylene glycol, lactose, crospovidone, magnesium stearate, silicon dioxide, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "210"

More about Uro-458 (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)

Consumer resources

Other brands: Uribel, Uretron DS, Urin D/S, Uro-MP, ... +16 more

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.